Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jmig.2023.09.016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Robot-assisted myomectomy versus open surgery: Cost-effectiveness analysis.
J Gynecol Obstet Hum Reprod
December 2024
Assistance Publique-Hospitals of Paris, Department of Gynecological and Breast Surgery and Oncology, Pitié Salpêtrière Hospital, Paris, France; University Institute of Cancer (IUC), AP-HP, Sorbonne University, Paris, France; Saint-Antoine Research Center (CRSA), INSERM UMR_S_938, Biology and Therapeutics of Cancer, Sorbonne University, Paris, France. Electronic address:
Introduction: Fibroids are the most common benign uterine tumors. There are different possibilities for surgical approaches, and evaluating the cost of these operations is fundamental in modern surgery. The aim of our study is to evaluate the cost-effectiveness of robotic-assisted myomectomy (RAM) compared to open myomectomy (OM) in France.
View Article and Find Full Text PDFProgress in High Intensity Focused Ultrasound Ablation for Fertility Preservation Therapy of Uterine Fibroids and Adenomyosis.
Reprod Sci
January 2025
Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1, Shuaifuyuan, Wangfujing, Beijing, 100730, China.
Article Synopsis
- - High intensity focused ultrasound (HIFU) is a safe, non-invasive treatment for uterine fibroids and adenomyosis, offering low side effects and significant symptom relief while improving patients' quality of life.
- - HIFU preserves surrounding healthy tissue and is an effective alternative to myomectomy for women desiring fertility, with positive outcomes on pregnancy and live birth rates compared to other treatments.
- - Although HIFU shows promise in improving pregnancy intervals and maintaining ovarian function post-treatment, there are concerns about higher cesarean delivery rates and potential risks like uterine rupture, indicating a need for more comprehensive studies on its long-term safety and efficacy.
Clinical effectiveness of gasless laparoscopic myomectomy with the subcutaneous steel wire-lifting method for fibroids.
Asian J Surg
November 2024
Department of Obstetrics and Gynecology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku, Tokyo, 160-0023, Japan.
Article Synopsis
- The study evaluated the feasibility of gasless laparoscopic myomectomy (GLM) using the subcutaneous steel wire-lifting method (GLMS) in 1301 patients from 2008 to 2021.
- Results indicated that while GLMS had longer operation times and removed more and larger fibroids compared to traditional laparoscopic myomectomy, it also had lower intraoperative blood loss and acceptable complication rates.
- The findings suggest that GLMS is a safe and effective option for fibroid removal, especially in regions with lower BMI averages, though patients with severe obesity may face higher risks.
Comparison of Costs, Re-Intervention Rates, and Length of Hospital Stay for Three Uterus Sparing Interventions for Uterine Fibroids: A 2-Year Retrospective Claims Analysis.
Clinicoecon Outcomes Res
July 2024
Department of Urology, Hoag Hospital, Newport Beach, CA, USA.
Article Synopsis
- The study aimed to evaluate the two-year post-operative outcomes and healthcare costs of three uterus-sparing procedures for treating uterine fibroids in women who wish to maintain their uterus: LAP-RFA, myomectomy, and UAE.
- A total of 54 women were randomly assigned to undergo one of the procedures, and their results were compared to a larger group of women from insurance claims data.
- The findings revealed that LAP-RFA had the lowest costs and shortest hospital stays, while UAE had the highest costs and re-intervention rates, indicating that LAP-RFA may be the most cost-effective and efficient option among the three treatments for fibroids.
Robotic-assisted laparoscopic versus abdominal and laparoscopic myomectomy: A systematic review and meta-analysis.
Int J Gynaecol Obstet
September 2024
School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
Background: Myomectomy is the preferred treatment for women with uterine fibroids and fertility requirements. There are three modalities are used in clinical practice for myomectomy: abdominal myomectomy (AM), laparoscopic myomectomy (LM), and robot-assisted laparoscopic myomectomy (RLM).
Objectives: To compare the perioperative and postoperative outcomes of RLM, AM, and LM.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!